The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of sorafenib combined with on-demand transarterial chemoembolization for advanced stage hepatocellular carcinoma (Barcelona Clinic Liver Cancer stage C): STAB study.
 
Yozo Sato
Honoraria - Bayer Yakuhin; Medicon; TERUMO
 
Hideyuki Nishiofuku
No Relationships to Disclose
 
Taku Yasumoto
No Relationships to Disclose
 
Atsuhiro Nakatsuka
No Relationships to Disclose
 
Kunihiro Matsuo
No Relationships to Disclose
 
Yoshihisa Kodama
Honoraria - Sumitomo Dainippon
 
Daisuke Abo
No Relationships to Disclose
 
Hironao Okubo
No Relationships to Disclose
 
Haruyuki Takaki
No Relationships to Disclose
 
Yoshitaka Inaba
Honoraria - Astellas Pharma; Bayer; Eisai; Kyowa Hakko Kirin; Medicon
 
Koichiro Yamakado
Honoraria - Eisai; Nippon Kayaku; Sumitomo Dainippon
 
Shozo Hirota
No Relationships to Disclose